Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving gemcitabine together with docetaxel works in
treating patients with recurrent or persistent uterine cancer. Drugs used in chemotherapy,
such as gemcitabine and docetaxel, work in different ways to stop the growth of tumor cells,
either by killing the cells or by stopping them from dividing. Giving more than one drug
(combination chemotherapy) may kill more tumor cells.